← Back to Search

Motivational Interview for Colorectal Cancer

N/A
Waitlist Available
Led By Jennifer Hatcher, RN, PhD
Research Sponsored by University of Kentucky
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will compare the effects of a culturally targeted intervention designed to assist participants to identify and overcome individual barriers to colorectal cancer (CRC) and to promote CRC screenings using motivational interviewing (Ml) delivered by a lay health advisor (LHA) compared to the current standard-of-care (distribution of a brochure describing CRC screening services offered by the hospital) on CRC screening compliance.

Eligible Conditions
  • Colorectal Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Colorectal Carcinoma

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Motivational InterviewExperimental Treatment1 Intervention
Subjects will engage in a brief motivational interview to establish an action plan and discuss follow-up interviews a 3 and 6 months post ED visit
Group II: Standard of CareActive Control1 Intervention
Subjects will be provided a standard of care colorectal cancer screening brochure at the time of ED visit
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Motivational interview
2022
N/A
~1940

Find a Location

Who is running the clinical trial?

University of KentuckyLead Sponsor
190 Previous Clinical Trials
220,531 Total Patients Enrolled
Jennifer Hatcher, RN, PhDPrincipal InvestigatorUniversity of Kentucky
~17 spots leftby Nov 2025